No rebound psychosis in a case of switching from clozapine to quetiapine;Umstellung von clozapin auf quetiapin ohne rebound-psychose

Psychiatrische Praxis

Volumn 33, Issue 2, 2006, Pages 93-94

  Walther, Sebastian ^a   Baciu, Dan ^a  

^a Psychiatrische Universitatsklinik   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OLANZAPINE; QUETIAPINE;

ADULT; ARTICLE; CASE REPORT; DOPAMINE RELEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MENTAL DISEASE; PARANOID SCHIZOPHRENIA; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REBOUND; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; BRIEF PSYCHIATRIC RATING SCALE; CLOZAPINE; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; HUMANS; MALE; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE D2; RECURRENCE; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 33644961250     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-866987     Document Type: Article

References (15)

1. Ekblom B, Eriksson K, Lindstrom LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology (Berl) 1984; 83: 293-294
2. Parsa MA, Lahham YH al, Ramirez LF, Meltzer HY. Prolonged psychotic relapse after abrupt clozapine withdrawal. J Clin Psychopharmacol 1993; 13: 154-155
3. Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996; 22: 591-595
4. Stanilla JK, Leon J de, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997; 58: 252-255
5. Leon J de, Stanilla JK, White AO, Simpson GM. Anticholinergics to treat clozapine withdrawal. J Clin Psychiatry 1994; 55: 119-120
6. 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 1999; 156: 876-884
7. Coyle JT. The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol 2004; 68: 1507-1514
8. Tsai GE, Yang P, Chung LC, Tsai IC, Tsai CW, Coyle JT. D-Serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry 1999; 156: 1822-1825
9. Javitt DC, Duncan L, Balla A, Sershen H. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action. Mol Psychiatry 2005; 10: 275-287
10. Williams JB, Mallorga PJ, Jeffrey CP, Pettibone DJ, Sur C. Effects of typical and atypical antipsychotics on human glycine transporters. Schizophr Res 2004; 71: 103-112
11. Javitt DC, Hashim A, Sershen H. Modulation of striatal dopamine release by glycine transport inhibitors. Neuropsychopharmacology 2005; 30: 649-656
12. Kumar V, Brecher M. Psychopharmacology of atypical antipsychotics and clinical outcomes in elderly patients. J Clin Psychiatry 1999; 60 (suppl 13): 5-9
13. Gründer G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 2003; 60: 974-977
14. Swainston HT, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004; 64: 1715-1736
15. Mass R, Burmeister J, Krausz M. Dimensionale Struktur der deutschen Version der Brief Psychiatric Rating Scale (BPRS). Nervenarzt 1997; 68: 239-244